BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 6488654)

  • 21. Diphosphonates in the evaluation of metabolic bone disease.
    Fogelman I; Smith ML
    Clin Rheumatol; 1982 Mar; 1(1):41-4. PubMed ID: 6236012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonspecific tissue accumulation of diffusible radionuclide imaging agents in areas of inflammation.
    Moallem A
    Clin Nucl Med; 1992 Jan; 17(1):4-6. PubMed ID: 1544261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pitfalls of absent or faint kidney sign or bone scan.
    Constable AR; Cranage RW
    J Nucl Med; 1981 Jul; 22(7):658. PubMed ID: 6454765
    [No Abstract]   [Full Text] [Related]  

  • 24. Occult gastric bleeding demonstrated by bone scan and Tc-99m-DTPA renal scan.
    Lee VW; Leiter BE; Weitzman F; Shapiro JH
    Clin Nucl Med; 1981 Oct; 6(10):470-3. PubMed ID: 6457714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone-seeking properties of Tc-99m carbonyl diphosphonic acid, dihydroxy-methylene diphosphonic acid and monohydroxy-methylene phosphoinic acid: concise communication.
    Wang TS; Fawwaz RA; Johnson LJ; Mojdehi GE; Johnson PM
    J Nucl Med; 1980 Aug; 21(8):767-70. PubMed ID: 7400832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Poor renal uptake of Tc-99m DMSA and Tc-99m MDP in a patient with Fanconi syndrome and near normal glomerular filtration rate.
    Kim SE; Cho JT; Lee DS; Chung JK; Kim S; Lee MC; Lee JS; Koh CS
    Clin Nucl Med; 1995 Mar; 20(3):215-9. PubMed ID: 7750213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Whole body bone scintigram with 99mTc-HMDP (technetium-99m-hydroxy methylene diphosphonate) (author's transl)].
    Isobe Y; Ko S; Umegaki Y; Takahashi S; Kawaguchi N; Wada S; Matsumoto S
    Radioisotopes; 1981 Nov; 30(11):606-8. PubMed ID: 7335900
    [No Abstract]   [Full Text] [Related]  

  • 28. A clinical comparison of MDP and DMAD.
    Rosenthall L; Stern J; Arzoumanian A
    Clin Nucl Med; 1982 Sep; 7(9):403-6. PubMed ID: 6214358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Superscan prediction--another benefit of early renal views in bone scans.
    Kajubi SK; Chayes ZW
    J Nucl Med; 1985 Apr; 26(4):428-9. PubMed ID: 3156977
    [No Abstract]   [Full Text] [Related]  

  • 30. A comparison of bone imaging with Tc-99m DPD and Tc-99m MDP: concise communication.
    Buell U; Kleinhans E; Zorn-Bopp E; Reuschel W; Muenzing W; Moser EA; Seiderer M
    J Nucl Med; 1982 Mar; 23(3):214-7. PubMed ID: 6460854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical comparison of bone scintigraphy with 99Tcm-DPD, 99Tcm-HDP and 99Tcm-MDP.
    Bergqvist L; Brismar J; Cederquist E; Darte L; Naversten Y; Palmer J
    Acta Radiol Diagn (Stockh); 1984; 25(3):217-23. PubMed ID: 6236672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of rhabdomyolysis with technetium-99m HDP bone imaging.
    Menendez IC; Lin DS; Kutka N
    Clin Nucl Med; 1985 Nov; 10(11):823. PubMed ID: 4075678
    [No Abstract]   [Full Text] [Related]  

  • 33. New vistas on bone scintigraphy.
    Nucl Med Commun; 1984 Jun; 5(6):359-60. PubMed ID: 6241663
    [No Abstract]   [Full Text] [Related]  

  • 34. Quantitation of differential renal function with Tc-99m MDP.
    Vieras F; Achong DM; Tulchinsky M; Smith JJ
    Clin Nucl Med; 1991 Sep; 16(9):649-51. PubMed ID: 1934826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Which diphosphonate for routine bone scintigraphy (MDP, HDP or DPD)?
    Frühling J; Verbist A; Balikdjian D
    Nucl Med Commun; 1986 Jun; 7(6):415-25. PubMed ID: 3748485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver uptake and increased renal uptake of Tc-99m HMDP in a patient with iron overload.
    Ohta H
    Clin Nucl Med; 2001 Feb; 26(2):164-5. PubMed ID: 11201486
    [No Abstract]   [Full Text] [Related]  

  • 37. [Bone scintigraphy with 99mTc-hydroxy methylene diphosphonate (99mTc-HMDP) (author's transl)].
    Okahashi S; Ishimaru T; Maeda H; Sakata T; Yamasaki K; Akagi H
    Radioisotopes; 1981 Aug; 30(8):458-60. PubMed ID: 7335921
    [No Abstract]   [Full Text] [Related]  

  • 38. Increased technetium-99 m hydroxy diphosphonate soft tissue uptake on bone scintigraphy in chronic kidney disease patients with secondary hyperparathyroidism: correlation with hyperphosphataemia.
    Enevoldsen LH; Heaf J; Højgaard L; Zerahn B; Hasbak P
    Clin Physiol Funct Imaging; 2017 Mar; 37(2):131-136. PubMed ID: 26148143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison between the diagnostic efficacy of 99mTc-MDP, 99mTc-DPD and 99mTc-HDP for the detection of bone metastases.
    Pauwels EK; Blom J; Camps JA; Hermans J; Rijke AM
    Eur J Nucl Med; 1983; 8(3):118-22. PubMed ID: 6220908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Scintigraphy using a technetium 99m-labelled anti-E-selectin Fab fragment in rheumatoid arthritis.
    Jamar F; Houssiau FA; Devogelaer JP; Chapman PT; Haskard DO; Beaujean V; Beckers C; Manicourt DH; Peters AM
    Rheumatology (Oxford); 2002 Jan; 41(1):53-61. PubMed ID: 11792880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.